
Nectin-4 expression was analyzed in urothelial bladder cancer (UBC) across 314 patients. Positivity was observed in 63% of primary tumours and 87% of lymph node metastases, with higher expression in luminal subtypes and micropapillary/pure urothelial histologies. Basal, mesenchymal, and neuroendocrine subtypes showed minimal expression.
Like
Save
Share